Mengke Pharmaceutical announced that the company previously disclosed that the wholly-owned subsidiary Mengke America sued Medpace over a contract dispute. Recently, the United States of America received a notice from the Western Division of the U.S. District Court for the Southern District of Ohio, and Medpace filed a counterclaim; as of the date of disclosure of the announcement, the case had not yet been tried.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.